Breaking News Instant updates and real-time market news.

MLCO

Melco Resorts & Entertainment

$22.08

0.56 (2.60%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47

Melco Resorts & Entertainment subsidiary provides update on IPO

Studio City International provided an update to its announcement made on August 14, 2017 regarding the confidential submission of a draft registration statement for the proposed initial public offering, or IPO, of American Depositary Shares, or ADS, representing ordinary shares of Studio City. Studio City has been continuing its preparations for the proposed IPO, which is expected to commence as market conditions permit and remains subject to the SEC declaring the registration statement effective. The ADSs may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

MLCO Melco Resorts & Entertainment
$22.08

0.56 (2.60%)

02/26/18
LYON
02/26/18
INITIATION
LYON
Outperform
Melco Resorts & Entertainment initiated with an Outperform at CLSA
03/08/18
STFL
03/08/18
NO CHANGE
STFL
Stifel returns from Macau trip with 'much more positive' view for 2018
Stifel analyst Steven Wieczynski said that after meeting with property managements and industry contacts in Macau recently he came back with a "much more positive/constructive view for 2018" than he was previously forecasting. It was clear that operators were "thrilled" with how the Chinese New Year holiday played out and demand post-CNY had continued to be strong, especially on the VIP side, Wieczynski tells investors. He maintains his Buy rating on Las Vegas Sands (LVS) and Hold ratings on MGM Resorts (MGM) and Wynn Resorts (WYNN). Melco Resorts (MLCO) is another publicly traded company in the Macau gaming space.
07/10/18
WOLF
07/10/18
UPGRADE
WOLF
Outperform
Melco Resorts upgraded to Outperform from Peer Perform at Wolfe Research
07/23/18
ROTH
07/23/18
NO CHANGE
Target $41
ROTH
Buy
Melco shares are 'near a bottom,' says Roth Capital
Despite lowering his Q2 EBITDA estimate, Roth Capital analyst David Bain believes shares of Melco Resorts & Entertainment are "near a bottom." The analyst lowered his Q2 property EBITDA estimate to $348.4M from $355.3M, below the consensus at $377.8M, to reflect a final surge of construction disruption at Melco's flagship, City of Dreams, ahead of the June 15 opening of Morpheus, and slightly lower than anticipated May and June Macau gross gaming revenue. The stock's multiple is now near historical lows, which is "not sustainable," Bain tells investors in a research note. He keeps a Buy rating on Melco Resorts & Entertainment with a $41 price target.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,166.21

-20.87 (-1.76%)

, GOOGL

Alphabet Class A

$1,172.22

-19.34 (-1.62%)

06:26
09/24/18
09/24
06:26
09/24/18
06:26
Periodicals
White House considers antitrust probe at Google, Facebook for 'bias,' BI says »

The White House is…

GOOG

Alphabet

$1,166.21

-20.87 (-1.76%)

GOOGL

Alphabet Class A

$1,172.22

-19.34 (-1.62%)

FB

Facebook

$162.90

-3.16 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

AMAL

Amalgamated Bank

$18.69

0.57 (3.15%)

06:26
09/24/18
09/24
06:26
09/24/18
06:26
Earnings
Amalgamated Bank reports Q2 core EPS 40c, consensus 34c »

Net Interest Margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Downgrade
Nutanix rating change  »

Nutanix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

HZNP

Horizon Pharma

$18.82

-0.02 (-0.11%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Recommendations
Horizon Pharma analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 27

    Nov

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Syndicate
Breaking Syndicate news story on Nutanix »

Nutanix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

APO

Apollo Global

$36.08

0.87 (2.47%)

, ATH

Athene Holding

$53.37

0.17 (0.32%)

06:23
09/24/18
09/24
06:23
09/24/18
06:23
Periodicals
Apollo criticized over scale of fees to affiliate life insurer, FT reports »

Imran Siddiqui, a former…

APO

Apollo Global

$36.08

0.87 (2.47%)

ATH

Athene Holding

$53.37

0.17 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

, SHPG

Shire

$178.32

-1.68 (-0.93%)

06:22
09/24/18
09/24
06:22
09/24/18
06:22
Periodicals
Top Takeda investor 'skeptical' about Shire takeover bid, Sunday Times reports »

One of the top 10…

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 22

    Oct

  • 21

    Dec

AGTC

Applied Genetic

$4.40

-0.05 (-1.12%)

, NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

06:20
09/24/18
09/24
06:20
09/24/18
06:20
Upgrade
Applied Genetic, Nightstar Therapeutics, Biogen rating change  »

Applied Genetic upgraded…

AGTC

Applied Genetic

$4.40

-0.05 (-1.12%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

BIIB

Biogen

$343.77

2.49 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

  • 03

    Oct

  • 16

    Oct

  • 17

    Oct

  • 22

    Oct

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

, WMT

Walmart

$95.85

0.1 (0.10%)

06:17
09/24/18
09/24
06:17
09/24/18
06:17
Periodicals
FreshDirect's deliveries stumble amid move, increased competition, WSJ reports »

FreshDirect says…

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

WMT

Walmart

$95.85

0.1 (0.10%)

KR

Kroger

$29.95

0.77 (2.64%)

ADRNY

Ahold Delhaize

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

KRP

Kimbell Royalty Partners

$22.15

0.01 (0.05%)

06:17
09/24/18
09/24
06:17
09/24/18
06:17
Hot Stocks
Kimbell Royalty Partners changes tax status to taxable entity »

Kimbell Royalty Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$27.53

0.01 (0.04%)

06:16
09/24/18
09/24
06:16
09/24/18
06:16
Downgrade
Sprouts Farmers Market rating change  »

Sprouts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

AKTS

Akoustis

$8.20

-0.15 (-1.80%)

06:16
09/24/18
09/24
06:16
09/24/18
06:16
Recommendations
Akoustis analyst commentary  »

Akoustis on track to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

06:14
09/24/18
09/24
06:14
09/24/18
06:14
Periodicals
Comcast CEO pledges to preserve Sky's independence, FT reports »

Comcast (CMCSA, CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

DIS

Disney

$110.72

-0.9 (-0.81%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

WCG

WellCare

$304.42

2.41 (0.80%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Hot Stocks
WellCare elects former Louisiana governor Bobby Jindal to board »

WellCare Health Plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Periodicals
U.S., China impose new tariffs on each other's goods, Reuters reports »

The U.S. and China…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$77.63

0.45 (0.58%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Hot Stocks
Michael Patsalos-Fox succeeds John Klein as Cognizant chairman »

Cognizant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 16

    Nov

KVHI

KVH Industries

06:12
09/24/18
09/24
06:12
09/24/18
06:12
Upgrade
KVH Industries rating change  »

KVH Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

06:12
09/24/18
09/24
06:12
09/24/18
06:12
Upgrade
United Natural Foods rating change  »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

KTWO

K2M Group

$27.30

0.02 (0.07%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Downgrade
K2M Group rating change  »

K2M Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ANGI

Angi Homeservices

$22.53

-0.59 (-2.55%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Conference/Events
Angi Homeservices management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

GHG

GreenTree Hospitality

$12.96

-0.54 (-4.00%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Initiation
GreenTree Hospitality initiated  »

GreenTree Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SA

Seabridge Gold

$11.25

-0.2 (-1.75%)

06:10
09/24/18
09/24
06:10
09/24/18
06:10
Hot Stocks
Seabridge Gold says KSM Project in British Columbia meeting objectives »

Seabridge Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ENDP

Endo

$16.11

-0.24 (-1.47%)

06:09
09/24/18
09/24
06:09
09/24/18
06:09
Hot Stocks
Endo agrees to additional stat of FDA litigation »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

HJLI

Hancock Jaffe Laboratories

$2.62

0.09 (3.56%)

06:08
09/24/18
09/24
06:08
09/24/18
06:08
Hot Stocks
Hancock Jaffe Laboratories submits application to INVIMA for VenoValve trial »

Hancock Jaffe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.